These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22391565)

  • 1. Low dose IR-induced IGF-1-sCLU expression: a p53-repressed expression cascade that interferes with TGFβ1 signaling to confer a pro-survival bystander effect.
    Klokov D; Leskov K; Araki S; Zou Y; Goetz EM; Luo X; Willson D; Boothman DA
    Oncogene; 2013 Jan; 32(4):479-90. PubMed ID: 22391565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IR-inducible clusterin gene expression: a protein with potential roles in ionizing radiation-induced adaptive responses, genomic instability, and bystander effects.
    Klokov D; Criswell T; Leskov KS; Araki S; Mayo L; Boothman DA
    Mutat Res; 2004 Dec; 568(1):97-110. PubMed ID: 15530543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein.
    Criswell T; Klokov D; Beman M; Lavik JP; Boothman DA
    Cancer Biol Ther; 2003; 2(4):372-80. PubMed ID: 14508108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM-dependent IGF-1 induction regulates secretory clusterin expression after DNA damage and in genetic instability.
    Goetz EM; Shankar B; Zou Y; Morales JC; Luo X; Araki S; Bachoo R; Mayo LD; Boothman DA
    Oncogene; 2011 Sep; 30(35):3745-54. PubMed ID: 21460853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpression.
    Wang Y; Wang X; Zhao H; Liang B; Du Q
    J Chemother; 2012 Dec; 24(6):348-57. PubMed ID: 23174100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed activation of insulin-like growth factor-1 receptor/Src/MAPK/Egr-1 signaling regulates clusterin expression, a pro-survival factor.
    Criswell T; Beman M; Araki S; Leskov K; Cataldo E; Mayo LD; Boothman DA
    J Biol Chem; 2005 Apr; 280(14):14212-21. PubMed ID: 15689620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM regulates insulin-like growth factor 1-secretory clusterin (IGF-1-sCLU) expression that protects cells against senescence.
    Luo X; Suzuki M; Ghandhi SA; Amundson SA; Boothman DA
    PLoS One; 2014; 9(6):e99983. PubMed ID: 24937130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin.
    Ma X; Bai Y
    Mol Med Rep; 2012 Dec; 6(6):1433-7. PubMed ID: 23027041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.
    Leskov KS; Araki S; Lavik JP; Gomez JA; Gama V; Gonos ES; Trougakos IP; Matsuyama S; Boothman DA
    J Biol Chem; 2011 Nov; 286(46):40083-90. PubMed ID: 21953454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
    Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
    Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chaperone activity of clusterin is dependent on glycosylation and redox environment.
    Rohne P; Prochnow H; Wolf S; Renner B; Koch-Brandt C
    Cell Physiol Biochem; 2014; 34(5):1626-39. PubMed ID: 25402950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I induces CLU expression through Twist1 to promote prostate cancer growth.
    Takeuchi A; Shiota M; Beraldi E; Thaper D; Takahara K; Ibuki N; Pollak M; Cox ME; Naito S; Gleave ME; Zoubeidi A
    Mol Cell Endocrinol; 2014 Mar; 384(1-2):117-25. PubMed ID: 24491388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate transcriptional and translational repression of p53 by TGF-β1 impairs the stress response.
    López-Díaz FJ; Gascard P; Balakrishnan SK; Zhao J; Del Rincon SV; Spruck C; Tlsty TD; Emerson BM
    Mol Cell; 2013 May; 50(4):552-64. PubMed ID: 23706820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer.
    Bhutia SK; Das SK; Kegelman TP; Azab B; Dash R; Su ZZ; Wang XY; Rizzi F; Bettuzzi S; Lee SG; Dent P; Grant S; Curiel DT; Sarkar D; Fisher PB
    J Cell Physiol; 2012 May; 227(5):1805-13. PubMed ID: 21732348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.
    Wang C; Jiang K; Kang X; Gao D; Sun C; Li Y; Sun L; Zhang S; Liu X; Wu W; Yang P; Guo K; Liu Y
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2308-20. PubMed ID: 23010347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.
    Lee JY; Kim HJ; Rho SB; Lee SH
    Oncotarget; 2016 Apr; 7(14):18541-57. PubMed ID: 26988917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
    Zhang B; Liu ZM; Hao FG; Wang M
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.